
Aveed
Testosterone Undecanoate
- SKU
- 67979-511
- Mfr
- Endo USA, Inc.
3 ml in 1 vial, single-use, 1 vial, single-use in 1 carton
$1,985.31
Price for one pack
Controlled medicine — prescription required. Upload your prescription at checkout or email it to us after ordering. We ship once a pharmacist has checked it and confirmed it with your prescriber. How it works
AVEED is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
- Strength
- Testosterone Undecanoate 250 mg/mL
- Unit of measure
- Per mL
- Dosage form
- Injection
- Route
- Intramuscular
Pharmacologic class
- Androgen Receptor AgonistsMechanism
- AndrogenEstablished class
- AndrostanesChemical structure
- Brand name
- Aveed
- Generic name
- Testosterone Undecanoate
- Manufacturer
- Endo USA, Inc.
- Product NDC (SKU)
- 67979-511
- Active ingredients
- Testosterone Undecanoate 250 mg/mL
- Unit of measure
- Per mL
- Dosage form
- Injection
- Route
- Intramuscular
- DEA schedule
- CIII
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application number
- NDA022219
- Marketed since
- March 5, 2014
- Label revised
- July 15, 2025
| Package NDC | Description |
|---|---|
| 67979-511-43 | 1 VIAL, SINGLE-USE in 1 CARTON (67979-511-43) / 3 mL in 1 VIAL, SINGLE-USE |
Reading this NDC
67979-511-43
- 01Labeler code
- Endo USA, Inc.
- 02Product code
- Aveed, injection
- 03Package code
- 1 vial, single-use in 1 carton (67979-511-43) / 3 ml in 1 vial, single-use
Endogenous androgens, including testosterone and dihydrotestosterone (DHT) are responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include the growth and maturation of prostate, seminal vesicles, penis, and scrotum; the development of male hair distribution, such as facial, pubic, chest, and axillary hair; laryngeal enlargement; vocal cord thickening; and alterations in body musculature and fat distribution.
Male hypogonadism, a clinical syndrome resulting from insufficient secretion of testosterone, has 2 main etiologies. Primary hypogonadism is caused by defects of the gonads, such as Klinefelter’s syndrome or Leydig cell aplasia, whereas secondary hypogonadism is the failure of the hypothalamus (or pituitary) to produce sufficient gonadotropins (FSH, LH).
Warning: Serious pulmonary oil microembolism (pome) reactions and anaphylaxis
Serious POME reactions, involving urge to cough, dyspnea, throat tightening, chest pain, dizziness, and syncope; and episodes of anaphylaxis, including life-threatening reactions, have been reported to occur during or immediately after the administration of testosterone undecanoate injection. These reactions can occur after any injection of testosterone undecanoate during the course of therapy, including after the first dose.
Following each injection of AVEED, observe patients in the healthcare setting for 30 minutes in order to provide appropriate medical treatment in the event of serious POME reactions or anaphylaxis. Because of the risks of serious POME reactions and anaphylaxis, AVEED is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the AVEED REMS Program.
WARNING: SERIOUS PULMONARY OIL MICROEMBOLISM (POME) REACTIONS AND ANAPHYLAXIS See full prescribing information for complete boxed warning Serious POME reactions, involving urge to cough, dyspnea, throat tightening, chest pain, dizziness, and syncope; and episodes of anaphylaxis, including life-threatening reactions, have been reported to occur during or immediately after the administration of testosterone undecanoate injection.
These reactions can occur after any injection of testosterone undecanoate during the course of therapy, including after the first dose. Following each injection of Aveed, observe patients in the healthcare setting for 30 minutes in order to provide appropriate medical treatment in the event of serious POME reactions or anaphylaxis. Aveed is available only through a restricted program called the Aveed REMS Program.
AVEED is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals.
These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation.
These men have low testosterone serum concentrations but have gonadotropins in the normal or low range. AVEED should only be used in patients who require testosterone replacement therapy and in whom the benefits of the product outweigh the serious risks of POME and anaphylaxis. Limitations of Use Safety and efficacy of AVEED in men with “age-related hypogonadism” (also referred to as “late-onset hypogonadism”) have not been established.
Safety and efficacy of AVEED in males less than 18 years old have not been established. Aveed (testosterone undecanoate) injection is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired)
Hypogonadotropic hypogonadism (congenital or acquired)
Aveed should only be used in patients who require testosterone replacement therapy and in whom the benefits of the product outweigh the serious risks of pulmonary oil microembolism and anaphylaxis. Limitations of Use Safety and efficacy of Aveed in men with “age-related hypogonadism” have not been established. Safety and efficacy of Aveed in males less than 18 years old have not been established.
Read before you order

Low testosterone · 2 min read
Low testosterone: symptoms, causes and how it is diagnosed
The symptoms of low testosterone, why diagnosis needs two morning blood tests, and the causes doctors look for.

Low testosterone · 2 min read
Testosterone injections, gels and capsules compared
How testosterone cypionate, enanthate and undecanoate injections compare with gels and oral capsules, and how to choose.

Low testosterone · 2 min read
Testosterone therapy: monitoring, fertility and risks
Why testosterone therapy needs blood tests, how it affects fertility and red blood cells, and the side effects to report.
More in Low Testosterone
View all
Brand · Injection
Azmiro
Testosterone Cypionate 200 mg/mL
- SKU
- 24338-055
- Mfr
- Azurity Pharmaceuticals, Inc.
From $252.00Min. 2 packsPrescription required

Brand · Capsule
Jatenzo
Testosterone Undecanoate 158 mg/1
- SKU
- 69087-158
- Mfr
- TOLMAR Inc.
From $1,451.99Prescription required

Brand · Capsule
Kyzatrex
Testosterone Undecanoate 150 mg/1
- SKU
- 80603-103
- Mfr
- Marius Pharmaceuticals
From $298.96Min. 2 packsPrescription required

Brand · Gel
Natesto Nasal Gel
Testosterone 5.5 mg/.122g
- SKU
- 42667-5511
- Mfr
- Acerus Pharmaceuticals Corporation
From $612.99Prescription required